標(biāo)題: Titlebook: Esophageal Cancer; Diagnosis and Treatm Francisco Schlottmann,Lorenzo Ferri,Marco G. Patti Textbook 2023Latest edition The Editor(s) (if ap [打印本頁] 作者: Strategy 時(shí)間: 2025-3-21 16:40
書目名稱Esophageal Cancer影響因子(影響力)
書目名稱Esophageal Cancer影響因子(影響力)學(xué)科排名
書目名稱Esophageal Cancer網(wǎng)絡(luò)公開度
書目名稱Esophageal Cancer網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Esophageal Cancer被引頻次
書目名稱Esophageal Cancer被引頻次學(xué)科排名
書目名稱Esophageal Cancer年度引用
書目名稱Esophageal Cancer年度引用學(xué)科排名
書目名稱Esophageal Cancer讀者反饋
書目名稱Esophageal Cancer讀者反饋學(xué)科排名
作者: Infinitesimal 時(shí)間: 2025-3-21 21:32 作者: 無脊椎 時(shí)間: 2025-3-22 00:29
Transhiatal Esophagectomy,ons or radiotherapy or those with T4 tumors. Cancer of the distal esophagus and esophago-gastric junction are well suited for this procedure, as most of the dissection of the area involved by the cancer can be done under direct vision.作者: 堅(jiān)毅 時(shí)間: 2025-3-22 07:37 作者: 狂怒 時(shí)間: 2025-3-22 10:04
Colonic Interposition After Esophagectomy,duit, both of which require complex surgical procedures that must be carried out with expertise and knowledge to be successful. In this chapter, we describe our experience with the use of colon interposition.作者: conception 時(shí)間: 2025-3-22 16:42
Climate Change and Storytellingesion due to the chronic injury produced by repeated reflux episodes involves genetic mutations that can lead to a malignant transformation. The development of EAC is characterized by the progression from BE metaplasia to dysplasia, and ultimately invasive carcinoma.作者: conception 時(shí)間: 2025-3-22 21:03
https://doi.org/10.1007/978-90-481-9867-2ment of dysplastic Barrett’s esophagus and the resection of early-stage esophageal malignancies. Additionally, endoscopy can be utilized as a bridge for enteral nutrition as well as for palliation for unresectable disease.作者: 輕打 時(shí)間: 2025-3-22 23:51
Asha Humbal,Neha Chaudhary,Bhawana Pathakhe selection of tumors appropriate for endoscopic resection and review the technical approaches and outcomes of the two main technical approaches, including Endoscopic Mucosal Resection (EMR) and Endoscopic Submucosal Dissection (ESD).作者: AWRY 時(shí)間: 2025-3-23 02:48 作者: POWER 時(shí)間: 2025-3-23 06:37
Sustainable Development and Climate Change,oscopic submucosal dissection (ESD). However, no single modality can accurately stage every patient with esophageal cancer on its own. Given the crucial role of accurate staging in devising an optimal therapeutic approach, the use of a combination of these modalities is often necessary.作者: 好忠告人 時(shí)間: 2025-3-23 10:10
Mohammed H. I Dore,Peter SimciskoSCC). Frail patients with ESCC who are not fit for surgery should receive dCRT. For those who are considered fit for esophagectomy, decision between dCRT and trimodality therapy should be taken on a case-by-case basis. The use of dCRT in patients with esophageal adenocarcinoma is not supported by data.作者: Brochure 時(shí)間: 2025-3-23 16:39 作者: FACET 時(shí)間: 2025-3-23 18:50
Climate Change and Future Aestheticse providing oncologic benefit that is equal or superior to open approaches. This allows for better patient outcomes, especially in patients with multiple medical problems. In this chapter we provide our approach to minimally invasive Ivor Lewis esophagectomy, including surgical tips to avoid complications and intraoperative trouble shooting.作者: 消毒 時(shí)間: 2025-3-24 00:11 作者: 手勢 時(shí)間: 2025-3-24 04:43 作者: Thyroiditis 時(shí)間: 2025-3-24 07:51 作者: 我邪惡 時(shí)間: 2025-3-24 14:04
Esophageal Adenocarcinoma: Pathogenesis and Epidemiology,esion due to the chronic injury produced by repeated reflux episodes involves genetic mutations that can lead to a malignant transformation. The development of EAC is characterized by the progression from BE metaplasia to dysplasia, and ultimately invasive carcinoma.作者: 期滿 時(shí)間: 2025-3-24 16:18 作者: Gullible 時(shí)間: 2025-3-24 22:48
Endoscopic Management of Early Esophageal Cancer,he selection of tumors appropriate for endoscopic resection and review the technical approaches and outcomes of the two main technical approaches, including Endoscopic Mucosal Resection (EMR) and Endoscopic Submucosal Dissection (ESD).作者: 燒瓶 時(shí)間: 2025-3-25 03:13 作者: 成份 時(shí)間: 2025-3-25 04:08 作者: PANIC 時(shí)間: 2025-3-25 09:43 作者: 離開可分裂 時(shí)間: 2025-3-25 12:53
Esophageal Squamous Cell Cancer: Pathogenesis and Epidemiology,ignant conditions also play a role. Studying epidemiology and pathogenesis of the disease allows policymakers to enact public health policies to prevent the disease through health education and risk factors avoidance. Screening for early disease detection in high-risk populations could improve overall outcome.作者: 推遲 時(shí)間: 2025-3-25 17:44
Perioperative Care and Management of Post-operative Complications, impact on hospital length of stay, morbidity, and mortality. The most common postoperative complications are pneumonia, atrial fibrillation, anastomotic leak and chyle leak. Early identification and timely intervention are essential to minimize the effects of these potentially devastating complications.作者: arbovirus 時(shí)間: 2025-3-25 23:07
Textbook 2023Latest edition, clinical staging, treatment, and outcomes of patients with esophageal cancer. Chapters cover the epidemiology of the disease, latest diagnostic and staging tools, systemic therapies, and the current open and minimally invasive?surgical techniques including transhiatal,?Ivor Lewis and McKeown esoph作者: 尊嚴(yán) 時(shí)間: 2025-3-26 01:40
Esophageal Anatomy,, (c) its lymphatic distribution is abundant and erratic, (d) the organs and structures of the mediastinum frequently present anatomic variations, and (e) the classic anatomic description is different from clinical presentation. In addition, minimally invasive surgery also brought a restricted but m作者: Pander 時(shí)間: 2025-3-26 08:05 作者: spinal-stenosis 時(shí)間: 2025-3-26 11:37 作者: 生銹 時(shí)間: 2025-3-26 12:47
Endoscopy and Endoscopic Ultrasound for Esophageal Cancer, esophageal cancer are crucial to determine optimal treatment and potential for cure. Optical endoscopy and endoscopic ultrasound (EUS) are key components of this, enabling tissue diagnosis, tumor localization, tumor characterization, and locoregional staging. Endoscopy is also employed in the treat作者: 的染料 時(shí)間: 2025-3-26 20:29
Radiologic Evaluation of Esophageal Cancer,ic ultrasound (EUS), magnetic resonance imaging (MRI), and histopathologic based staging, which encompasses endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD). However, no single modality can accurately stage every patient with esophageal cancer on its own. Given the cruci作者: prick-test 時(shí)間: 2025-3-26 23:55 作者: Incumbent 時(shí)間: 2025-3-27 03:47 作者: 確保 時(shí)間: 2025-3-27 07:56
Multimodal Therapy for Locally Advanced Esophageal Cancer,e two diseases entities should be treated differently. It is clear that chemotherapy or chemoradiotherapy should be given before surgery; however, perioperative systemic regimens have taken over the landscape for patients with EAC in many centers around the world. Although significant regional diffe作者: Interlocking 時(shí)間: 2025-3-27 12:01
Definitive Chemoradiotherapy for Esophageal Cancer,diotherapy (dCRT) is at least equivalent to trimodality therapy in terms of long-term survival for patients with esophageal squamous cell carcinoma (ESCC). Frail patients with ESCC who are not fit for surgery should receive dCRT. For those who are considered fit for esophagectomy, decision between d作者: BRIBE 時(shí)間: 2025-3-27 16:48 作者: Obvious 時(shí)間: 2025-3-27 18:42 作者: gorgeous 時(shí)間: 2025-3-28 01:19
Transhiatal Esophagectomy,proper patients for this procedure. For instance, this approach is not ideal for patients with severe mediastinal adhesions secondary to prior operations or radiotherapy or those with T4 tumors. Cancer of the distal esophagus and esophago-gastric junction are well suited for this procedure, as most 作者: debris 時(shí)間: 2025-3-28 04:47 作者: Lipoprotein(A) 時(shí)間: 2025-3-28 09:58 作者: invulnerable 時(shí)間: 2025-3-28 12:54 作者: TEM 時(shí)間: 2025-3-28 17:06
Minimally Invasive McKeown Esophagectomy,tes of pulmonary complications, and faster recovery with shorter length of stay. MIE also results in less blood loss, reducing the need for blood transfusions. MIE is a demanding procedure but with the right training and proctoring can be safely adopted into practice without compromising the surgica作者: 拍下盜公款 時(shí)間: 2025-3-28 19:11 作者: byline 時(shí)間: 2025-3-28 23:11 作者: Gullible 時(shí)間: 2025-3-29 05:36
a variety of medical disciplines, with contributions from world renowned surgeons, gastroenterologists, and medical oncologists.? Thanks to its multidisciplinary authorship, this book represents a unique resource for anybody who takes care of patients with esophageal cancer..978-3-031-39088-3978-3-031-39086-9作者: Ige326 時(shí)間: 2025-3-29 07:16
Advances in Global Change Researchry seems to be the best treatment option available. The addition of adjuvant checkpoint inhibition in the presence of residual disease seems to be the best augment for this approach. However, significant regional differences exist in this setting as well with docetaxel-based therapy emerging as a vi作者: interrupt 時(shí)間: 2025-3-29 12:33 作者: HILAR 時(shí)間: 2025-3-29 18:02
Multimodal Therapy for Locally Advanced Esophageal Cancer,ry seems to be the best treatment option available. The addition of adjuvant checkpoint inhibition in the presence of residual disease seems to be the best augment for this approach. However, significant regional differences exist in this setting as well with docetaxel-based therapy emerging as a vi作者: ingrate 時(shí)間: 2025-3-29 20:12
Robotic Assisted Ivor Lewis Esophagectomy,ocus. Herein, we review the technique of a completely robotic assisted Ivor Lewis esophagectomy. We discuss the operative technique for both the abdominal and thoracic portions, including demonstration of port placement as well as ‘troubleshooting’ scenarios intraoperatively.作者: indigenous 時(shí)間: 2025-3-30 01:51
Explicating Institutional Legitimacy, (c) its lymphatic distribution is abundant and erratic, (d) the organs and structures of the mediastinum frequently present anatomic variations, and (e) the classic anatomic description is different from clinical presentation. In addition, minimally invasive surgery also brought a restricted but m作者: Crepitus 時(shí)間: 2025-3-30 06:19
Climate Change and Personal Food Choices,redominant cell type worldwide. The majority of squamous cell cancers are from the East. Risk factors for the development of esophageal squamous cell carcinoma differ between high- and low-incidence regions. Tobacco and alcohol intake are the two major risks factors for esophageal squamous cell carc作者: FATAL 時(shí)間: 2025-3-30 11:06 作者: Alveolar-Bone 時(shí)間: 2025-3-30 15:56 作者: prosthesis 時(shí)間: 2025-3-30 16:45 作者: 異端 時(shí)間: 2025-3-30 22:38 作者: 悠然 時(shí)間: 2025-3-31 02:02
Asha Humbal,Neha Chaudhary,Bhawana Pathakntly, the potentially reduced quality of life, endoscopic therapy represents a favorable approach where appropriate. Endoscopic resection therapies have been successfully applied to selected patients with early tumors of the esophagus with equivalent oncological outcomes. This chapter will address t作者: Crumple 時(shí)間: 2025-3-31 07:11
Advances in Global Change Researche two diseases entities should be treated differently. It is clear that chemotherapy or chemoradiotherapy should be given before surgery; however, perioperative systemic regimens have taken over the landscape for patients with EAC in many centers around the world. Although significant regional diffe作者: Exuberance 時(shí)間: 2025-3-31 09:52
Mohammed H. I Dore,Peter Simciskodiotherapy (dCRT) is at least equivalent to trimodality therapy in terms of long-term survival for patients with esophageal squamous cell carcinoma (ESCC). Frail patients with ESCC who are not fit for surgery should receive dCRT. For those who are considered fit for esophagectomy, decision between d作者: 色情 時(shí)間: 2025-3-31 16:58
Kenneth D. Frederick,David C. Majorhe biology and the potential role of identifying biomarkers of response, and offers a comprehensive overview of the clinical trials that have evaluated the use of immunotherapy in different settings of the treatment of esophageal cancer.作者: Kidnap 時(shí)間: 2025-3-31 18:35 作者: Microgram 時(shí)間: 2025-4-1 00:13 作者: MIRTH 時(shí)間: 2025-4-1 05:11 作者: 剛開始 時(shí)間: 2025-4-1 09:04 作者: 金哥占卜者 時(shí)間: 2025-4-1 11:30
